If you’ve noticed purple or reddish spots on your skin that don’t fade when you press on them, you’re likely dealing with purpura — and managing purpura rash starts with figuring out why it’s happening. Purpura isn’t a disease itself; it’s a visible sign that blood is leaking from small vessels beneath the skin. The spots can range from tiny pinpoints (called petechiae, under 2mm) to large bruise-like patches (ecchymoses, over 1cm).
Because gravity and vein pressure make the lower limbs a common first site, spots appearing as purpura on the legs often offer the earliest clue about which underlying process is driving the bleeding.
The critical first step is determining whether your platelet count is low. A normal platelet count runs between 150,000 and 400,000/µL. If yours is below 50,000/µL, spontaneous purpura becomes increasingly likely, and below 10,000/µL, you’re at risk for life-threatening bleeding. This single lab value — your platelet count — splits purpura into two fundamentally different categories that require different treatment approaches.
What Exactly Is Purpura Rash?
Purpura describes any purple-red discoloration of the skin caused by blood escaping from capillaries or small blood vessels into the surrounding tissue. The key clinical feature: these spots do not blanch. Press a glass against the skin (the “glass test” or diascopy), and the color stays. This distinguishes purpura from erythema or other red rashes caused by dilated blood vessels.
Clinically, we classify purpura into two major categories:
- Thrombocytopenic purpura — platelet count is low (below 150,000/µL), meaning the blood can’t clot properly
- Non-thrombocytopenic purpura — platelet count is normal, and the problem lies in the blood vessels themselves or surrounding tissue
This distinction matters enormously because it changes the entire diagnostic workup and treatment plan.
Common Causes of Purpura by Type
| Thrombocytopenic Causes | Non-Thrombocytopenic Causes |
|---|---|
| Immune thrombocytopenic purpura (ITP) | Henoch-Schönlein purpura (IgA vasculitis) |
| Thrombotic thrombocytopenic purpura (TTP) | Senile (actinic) purpura — age-related skin fragility |
| Bone marrow failure (leukemia, aplastic anemia) | Steroid-induced purpura |
| Drug-induced thrombocytopenia (heparin, quinine) | Scurvy (vitamin C deficiency) |
| Disseminated intravascular coagulation (DIC) | Hypersensitivity vasculitis |
| Viral infections (HIV, hepatitis C, EBV) | Ehlers-Danlos syndrome |
In adults over 65, the most common cause I see in practice is senile purpura — those flat, dark purple patches on the forearms and hands caused by aging skin and sun damage. It’s cosmetically bothersome but medically benign. In children, Henoch-Schönlein purpura (HSP) is the most common vasculitis, affecting roughly 20 per 100,000 children annually, typically after an upper respiratory infection.
Symptoms Beyond the Spots
The purpura itself is obvious — but the accompanying symptoms often point to the underlying cause:
- Fever + purpura — think meningococcemia, DIC, or sepsis. This is a medical emergency.
- Joint pain + abdominal pain + purpura on the legs — classic triad of HSP
- Fatigue + easy bruising + heavy periods — suggests ITP or bone marrow disorder
- Neurological changes + fever + purpura — TTP until proven otherwise (mortality exceeds 90% if untreated)
- Purpura limited to forearms/hands in an elderly patient — likely senile purpura
Diagnostic Workup
When a patient presents with new purpura, here’s the systematic approach:
First-Line Labs
- Complete blood count (CBC) with differential — platelet count is the single most important value
- Peripheral blood smear — look for schistocytes (fragmented red cells suggesting TTP/DIC), blasts (leukemia), or platelet clumping (pseudothrombocytopenia)
- Coagulation studies — PT, aPTT, fibrinogen, D-dimer
- Basic metabolic panel and liver function tests
Second-Line Testing (Based on Clinical Suspicion)
- Inflammatory markers — ESR, CRP (elevated in vasculitis)
- ANA, anti-dsDNA — if lupus is suspected
- Skin biopsy — gold standard for diagnosing vasculitis; look for leukocytoclastic vasculitis or IgA deposits
- Bone marrow biopsy — if platelets are low and the cause isn’t obvious
- ADAMTS13 activity — if TTP is suspected (activity <10% is diagnostic)
Treatment and Managing Purpura Rash by Cause
There’s no single treatment for purpura because the treatment targets the underlying condition. Here’s how management breaks down:
Immune Thrombocytopenic Purpura (ITP)
First-line therapy is corticosteroids — typically prednisone 1 mg/kg/day for 2–4 weeks with a taper. About 60–80% of patients respond initially. For refractory cases, options include IV immunoglobulin (IVIg) for rapid platelet rise, rituximab, thrombopoietin receptor agonists (eltrombopag, romiplostim), or splenectomy in chronic cases. Treatment is generally indicated when platelets drop below 30,000/µL or when there’s active bleeding.
Henoch-Schönlein Purpura (HSP)
Most cases in children are self-limiting within 4–6 weeks. Management is supportive: NSAIDs for joint pain, hydration, and monitoring renal function (urinalysis every 1–2 weeks for 6 months). Corticosteroids are reserved for severe abdominal pain, significant renal involvement, or orchitis. Roughly 1–5% of children develop long-term kidney disease.
Senile Purpura
No specific treatment is needed. Moisturizing the skin, avoiding trauma, and protecting the forearms can help reduce new lesions. Some dermatologists recommend topical retinoids or arnica, though evidence is limited.
Drug-Induced Purpura
Discontinue the offending medication. Platelet counts typically recover within 5–7 days after drug cessation. Common culprits include heparin, quinine, sulfonamides, and certain antibiotics.
When to See a Doctor — Immediately
Not all purpura is urgent, but some presentations require emergency evaluation:
- Purpura spreading rapidly over hours with fever — this could be meningococcemia or DIC
- New purpura in a child with high fever and lethargy — don’t wait, go to the ER
- Purpura with confusion, fever, and dark urine — possible TTP, which requires urgent plasma exchange
- Any purpura with active bleeding — nosebleeds that won’t stop, blood in urine or stool, heavy menstrual bleeding
- New purpura after starting a medication — call your prescribing doctor the same day
For non-urgent purpura that’s stable and painless — such as a few spots on the forearms of an older adult — scheduling an appointment within a week is reasonable.
Frequently Asked Questions
Is purpura rash always serious?
No. Senile purpura in older adults is extremely common and harmless. However, new-onset purpura always warrants a medical evaluation because it can signal conditions like ITP, leukemia, or vasculitis. The seriousness depends entirely on the underlying cause.
Can purpura go away on its own?
Yes, in many cases. Individual purpura spots typically fade over 1–3 weeks as the body reabsorbs the leaked blood, transitioning from purple to brownish-yellow (similar to a bruise). HSP in children usually resolves completely within 4–6 weeks. But if new spots keep appearing, that signals an ongoing problem that needs treatment.
What’s the difference between purpura and a regular bruise?
Purpura and bruises (ecchymoses) are actually on the same spectrum — both result from blood leaking under the skin. The term “purpura” is typically used when the spots appear spontaneously or with minimal trauma, suggesting an underlying platelet or vascular problem. A bruise from bumping into a table is normal; waking up covered in unexplained bruises is purpura and needs evaluation.
Does purpura rash itch or hurt?
Classic purpura is typically painless and non-itchy — it’s flat and you can’t feel it by running your fingers over the skin. If the spots are raised (palpable purpura), that strongly suggests vasculitis and changes the diagnostic approach. Pain in the area may occur with deeper bleeding or if the underlying condition involves tissue inflammation.
What platelet count causes purpura?
Spontaneous petechiae generally appear when platelets fall below 30,000/µL. Significant purpura and mucosal bleeding become more common below 10,000–20,000/µL. However, non-thrombocytopenic purpura occurs with completely normal platelet counts — the problem is in the vessel walls or surrounding tissue, not the platelets.
